Rosenblatt Starts MKS Instruments (MKSI) at Buy
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Rosenblatt analyst Scott Graham initiates coverage on MKS Instruments (NASDAQ: MKSI) with a Buy rating and a price target of $162.00.
The analyst comments "We believe the company is well-positioned to benefit from multiple, long-term secular trends in the Semiconductor market, improvements in industrial and consumer demand in its Advanced Markets businesses and leverage its cost acumen into material growth in earnings in 2021-22. We also expect MKSI to use its highly liquid balance sheet to enhance shareholder value with acquisitions. But do see earnings constrained over the next 3 quarters by COVID-19-related end-user demand weakness and an air pocket in WFE capex."
Shares of MKS Instruments closed at $120.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: China Renaissance Starts Adagene Inc (ADAG) at Buy, 'Emerging leader in global antibody therapeutics'
- UPDATE: Stephens Starts SolarEdge Technologies (SEDG) at Overweight
- Rosenblatt Starts Cadence Designs (CDNS) at Buy
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Comments, Hot New Coverage, New Coverage
Related EntitiesEarnings, Rosenblatt
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!